This content is machine translated Dyslipidemia: "Treat-to-target" Risk-adapted individual LDL-C targets Together with arterial hypertension and diabetes mellitus, lipid metabolism disorders are among the most important modifiable cardiovascular risk factors. In addition to statins, various modern substance classes are now available...…
View Post 5 min This content is machine translated Modern lipid management Treating dyslipidemia in diabetes in a target-oriented manner Diabetes is associated with increased cardiovascular morbidity and mortality. Risk-stratified LDL cholesterol lowering is an important component of diabetes therapy and may improve clinical prognosis. In order to achieve the…
View Post 10 min This content is machine translated New AGLA guidelines Dyslipidemia – when to see a specialist? “The lower the better” – the approach to lower cholesterol levels as much as possible in patients at cardiovascular risk is more relevant than ever, according to the update of… CME-Test
View Post 4 min This content is machine translated Management of dyslipidemia Lipid-lowering agents for secondary prophylaxis also effective in elderly patients A recent meta-analysis published in the Lancet concluded that lipid lowering achieved comparable reductions in cardiovascular events in people over 75 years of age as in younger individuals. In elderly…
View Post 5 min This content is machine translated Peripheral arterial occlusive disease as a pandemic It is high time to act Arterial occlusive disease is a disease with multiple sites (coronary, cerebral, peripheral, and visceral). Cardiovascular risk factors must be treated aggressively even in the asymptomatic patient with PAOD. The pAVK…
View Post 2 min This content is machine translated Study meeting Sport and statins In the Lancet, American authors published the results of a study in which more than 10,000 male patients, former veterans, with a diagnosis of dyslipidemia were examined. These subjects, with…
